Author:
Suga Takuya,Shiina Mayu,Asami Yukihiro,Iwatsuki Masato,Yamamoto Tsuyoshi,Nonaka Kenichi,Masuma Rokuro,Matsui Hidehito,Hanaki Hideaki,Iwamoto Susumu,Onodera Hideyuki,Shiomi Kazuro,Ōmura Satoshi
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology
Reference23 articles.
1. Saga, T. & Yamaguchi, K. History of antimicrobial agents and resistant bacteria. Jpn. Med. Assoc. J. 52, 103–108 (2009).
2. Kondo, S., Iinuma, K., Yamamoto, H., Maeda, K. & Umezawa, H. Syntheses of 1-N-{(S-4-amino-2hydroxybutyry}-kanamycin B and -3′,4′-dideoxykanamycin B and -3',4'-dideoxykanamycin B active against kanamycin-resistant bacteria. J. Antibiot. 26, 412–415 (1973).
3. Kondo, S. et al. New 2''-amino derivatives of arbekacin, potent aminoglycoside antibiotics against methicillin-resistant Staphylococcus aureus. J. Antibiot. 46, 531–533 (1993).
4. Mikuniya, T. et al. Prevalence of drug resistant gene and changes in susceptibility of methicillin-resistant Staphylococcus aureus strains isolated from 1990 to 2006 in Japan to antimicrobial agents. Jpn. J. Chemother. 57, 37–40 (2009).
5. Kondo, S. Development of arbekacin and synthesis of new derivatives stable to enzymatic modifications by methicillin-resistant Staphylococcus aureus. Jpn J. Antibiot. 47, 561–574 (1994).
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献